FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to an eremomycin derivative which can be used in medicine and pharmaceutical industry, corresponding to formula:
,
where Py – independently denotes pyridin-2-yl, pyridin-3-yl, pyridin-4-yl, n=1–3, as well as its quaternized N-C10-20alkyl derivatives, hydrates, pharmacologically acceptable salts.
EFFECT: novel derivatives of eremomycin effective for treating bacterial infections caused by gram-positive bacteria.
4 cl, 11 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| NEW DERIVATIVES OF EREMOMYCIN AMIDE AND APPLICATION THEREOF FOR TREATING BACTERIAL INFECTIONS | 2020 |
|
RU2751334C1 |
| N-(GUANIDINOALKYL) AMIDES OF EREMOMYCIN AND THEIR USE FOR TREATING BACTERIAL INFECTIONS | 2022 |
|
RU2815029C1 |
| NEW SEMI-SYNTHETIC EREMOMYCINE DERIVATIVE AND ITS APPLICATION | 2016 |
|
RU2641912C1 |
| DERIVATIVES OF 1,4-DIOXIDE OF QUINOXALINE-2-CARBONITRILE INHIBITING TUMOUR CELLS GROWTH | 2016 |
|
RU2640304C1 |
| METHOD FOR INHIBITING TUMOR CELLS WITH NEW DERIVATIVES OF 3-TRIFLUOROMETHYLQUINOXALINE 1,4-DIOXIDE | 2020 |
|
RU2746395C1 |
| CHIMERIC ANTIBIOTICS BASED ON AZITHROMYCIN AND GLYCOPEPTIDE ANTIBIOTICS, HAVING ANTIBACTERIAL ACTIVITY AND SYNTHESIS METHOD THEREOF | 2014 |
|
RU2578604C1 |
| CHIMERIC ANTIBIOTICS BASED ON GLYCOPEPTIDES AND 11,12-CYCLIC CARBONATE AZITHROMYCIN AND METHOD FOR PRODUCTION THEREOF | 2014 |
|
RU2570425C1 |
| SEMI-SYNTHETIC DERIVATIVES OF HELIOMYCIN INHIBITING TUMOR GROWTH | 2016 |
|
RU2644780C2 |
| NOVEL HELIOMYCIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF INHIBITING TUMOR GROWTH | 2018 |
|
RU2670763C1 |
| NATAMYCIN AMIDES AND THEIR USE FOR THE TREATMENT OF FUNGAL INFECTIONS | 2022 |
|
RU2803742C1 |
